Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

Share Price is delayed by 15 minutes
Get Live Data
0.165    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.01 (6.25%)
Market Cap: £2.18m
VAL Live PriceLast checked at - London Stock Exchange

Intraday ValiRx Share Chart

Small caps: Cineworld, Aortech, African Eagle

Mon, 24th May 2010 07:52
Cinema chain Cineworld has signed a deal with Quintain Estates for a new multi-screen cinema at Wembley City, the retail park next door to Wembley station. Cineworld has signed a 25 year lease for a new nine screen cinema which will seat 1,800 people in total and is scheduled to open in 2013. It will be located adjacent to Wembley Stadium and Wembley Arena, forming a central part of the 280,000 sq ft leisure and retail hub. Construction is expected to commence on the site in 2011.Biomaterials and medical devices group Aortech today announced a non-exclusive technology licence and material supply agreement with a multi-billion dollar NYSE listed company to use the group's proprietary biostable co-polymer Elast-Eo as an integral part of a drug delivery platform for urological catheters.African Eagle is "delighted" with results of its phase 2 column and tank leach tests at the Dutwa nickel project in Tanzania.The tests show that Dutwa ore could be processed by either heap leaching or tank leaching at normal atmospheric pressure, without recourse to the high cost and hi-tech complications of high pressure acid leach (HPAL).Green technology company Ultima Networks made a pre-tax profit of £214,000 in 2009, down from £281,000 the previous year, on revenue down to £1.87m from £1.98m. "There remain challenges ahead in the economic conditions we face which will have an impact on all divisions of the business but we are confident that the milestones reached in 2009 will allow us to grow across all areas of the group," the firm said.It's also confident it will be able to raise enough money to build the solar parks planned for southern Italy.ValiRx, the biotech firm focused on cancer diagnostics and therapeutics for personalised medicine, has added an over the counter Chlamydia self-testing kit to its range of health screening products.The company has signed an agreement to market Biovei's Chlamydia kit in the UK and Ireland under ValiRx's SELFCheck brand. The SELFCheck Chlamydia kit will provide a test result within about 10 minutes, compared to a lag of four to five days for a laboratory test. Trading systems developer Patsystems said results for the year to end of April were in line with management's expectations while the company's strong pipeline underpins its belief that 2010 will be another strong year for the group."I am pleased to report that 2010 has started as strongly as we expected with the addition of Bursa Malaysia to our client list, good progress on several other sales prospects and continued double digit growth in our existing Asian client base," said Richard Last, the company's chairman.Oil and gas firm Roxi Petroleum narrowed pre-tax losses to $33.4m against the loss of $94.5m predominantly due to lower admin costs. "These are exciting times for Roxi and its shareholders, as we remain focused on increasing shareholder value in the near term. We are looking forward to a very active and productive period ahead of us," he said.Stratex International rose after the exploration and development company announced "positive results" from detailed sampling of the company's Megenta hot spring gold discovery in Ethiopia.Shares in Max Petroleum fell back after the Kazakhstan-focused oil and gas developer said reservoirs encountered during drilling at the Borkyldakty Field were 'structurally lower than expected, at or below their respective oil-water contacts.'

Related News

TRADING UPDATES: Maintel fundraising completes; ValiRx ends deal
22 Jun 2026

TRADING UPDATES: Maintel fundraising completes; ValiRx ends deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

IN BRIEF: ValiRx subsidiary Cytolytix granted "core" European patent
27 May 2026

IN BRIEF: ValiRx subsidiary Cytolytix granted "core" European patent

ValiRx PLC - London-based life science company - Majority-owned subsidiary Cytolytix Ltd has its European patent "Nanoparticle for Anti-Cancer Peptide...

TRADING UPDATES: IAG launches new buyback; Forgent settles legal case
15 May 2026

TRADING UPDATES: IAG launches new buyback; Forgent settles legal case

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

ValiRx News

IN BRIEF: ValiRx seeks up to GBP1.5 million for new research facility
13 Jan 2023

IN BRIEF: ValiRx seeks up to GBP1.5 million for new research facility

ValiRx PLC - Hatfield Heath, England-based life sciences company focused on early-stage cancer therapeutics and women's health - Raises GBP1 million f...

ValiRx shares fall on test extension, but optimistic of other assets
6 Dec 2022

ValiRx shares fall on test extension, but optimistic of other assets

(Alliance News) - ValiRx PLC on Tuesday saw shares drop, after extending its evaluation agreement with Hokkaido University to conduct further experime...

ValiRx forms new majority-owned breast cancer subsidiary
24 Oct 2022

ValiRx forms new majority-owned breast cancer subsidiary

(Sharecast News) - Women's health and cancer therapeutics company ValiRx announced the formation of a new partially-owned subsidiary, Cytolytix, on Mo...

ValiRx teams with King's College London for cancer project
24 Oct 2022

ValiRx teams with King's College London for cancer project

(Alliance News) - ValiRx PLC on Monday said it is making progress on its goal to introduce new academic projects into its portfolio, after launching s...

IN BRIEF: ValiRx shares up on new interim chief scientific officer
8 Sep 2022

IN BRIEF: ValiRx shares up on new interim chief scientific officer

ValiRx PLC - Nuneaton, England-based drug development company - Appoints Catherine Tralau-Stewart as interim chief scientific officer. Says she has ex...

EARNINGS UPDATES: Windward widens loss as operating expenses rise
31 Aug 2022

EARNINGS UPDATES: Windward widens loss as operating expenses rise

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

IN BRIEF: ValiRx shares jump on breast cancer drug candidate progress
13 Jul 2022

IN BRIEF: ValiRx shares jump on breast cancer drug candidate progress

ValiRx PLC - Nuneaton, England-based drug development company - Completes the evaluation of the impact of a peptide drug candidate against triple nega...

IN BRIEF:ValiRx gains GBP1.0 million from Turner Pope broker option
5 Jul 2022

IN BRIEF:ValiRx gains GBP1.0 million from Turner Pope broker option

ValiRx PLC - Nuneaton, England-based drug development company - Announces that the broker option granted to Turner Pope Investments Ltd has been fully...